Investor Relations

Codes

ISIN-code : BE0974328602
LEI-code : 9676001O8J81JR4HH394

Company-code: 0665.584.108

Directors

• Dirk Verstraete, managing director
• Guy De Vreese, managing director
• Philippe Van Acker, director
• Cavalli Consulting BVBA, represented by Marc Gryspeerdt, director

Shareholder’s Structure

• Share capital: EUR 12.438.001,27
• Number of outstanding shares as of March 29, 2019: 4.390.523
• Number of voting rights as of March 29, 2019: 4.390.523
• Each of the shares carries one voting right at the general meeting of shareholders No outstanding options or warrants have been issued that entitle their holder to shares, nor shares without voting rights.
• Ultimate Beneficial Owner (UBO):
  On March 29th, 2019 REMEDENT NV held 1.316.546 MiB shares representing circa 29,99% of MiB’s total share capital and voting rights.
  REMEDENT NV is for 99,99% owned by the American company Remedent Inc. stock listed on Nasdaq (https://www.nasdaq.com/markets/spos/company/remedent-inc-71235-55437). According to the last know shareholders’ records of Remedent Inc. dating from May 8th, 2018, no shareholder was owner of more than 25% of the shares of Remedent Inc. Since Mr. De Vreese is director of Remedent Inc., Mr. Guy De Vreese will be indicated as an indirect UBO of Metrics in Balance NV.

Contactpersoon

Dirk Verstraete
tel: +32 474 86 25 74
mail: info@metricsinbalance.com


Maatschappelijke zetel  

Zuiderlaan 1-3 bus 8
9000 Gent, Belgium

Euronext Access(TM) Paris : Euronext website

Meest recente notering: Metrics in Balance (MLMIB)